Acecainide
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Acecainide
- DrugBank Accession Number
- DB17602
- Background
Acecainide is an investigational anti-arrhythmia drug.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 277.368
Monoisotopic: 277.179026993 - Chemical Formula
- C15H23N3O2
- Synonyms
- 4'-((2-(diethylamino)ethyl)carbamoyl)acetanilide
- Acetylprocainamide
- Acetylprocainamide, n-
- Benzamide, 4-(acetylamino)-n-(2-(diethylamino)ethyl)-
- N-acetyl-procainamide
- N-acetylnovocainamide
- N-acetylprocainamide
- N-acetylprocaine amide
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 910Q707V6F
- CAS number
- 32795-44-1
- InChI Key
- KEECCEWTUVWFCV-UHFFFAOYSA-N
- InChI
- InChI=1S/C15H23N3O2/c1-4-18(5-2)11-10-16-15(20)13-6-8-14(9-7-13)17-12(3)19/h6-9H,4-5,10-11H2,1-3H3,(H,16,20)(H,17,19)
- IUPAC Name
- N-[2-(diethylamino)ethyl]-4-acetamidobenzamide
- SMILES
- CCN(CC)CCNC(=O)C1=CC=C(NC(C)=O)C=C1
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0041944
- ChemSpider
- 4189
- BindingDB
- 50151860
- ChEBI
- 60728
- ChEMBL
- CHEMBL1097
- ZINC
- ZINC000001999404
- Wikipedia
- Acecainide
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 1.02 Chemaxon pKa (Strongest Acidic) 13.73 Chemaxon pKa (Strongest Basic) 9.04 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 61.44 Å2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 82.41 m3·mol-1 Chemaxon Polarizability 32.18 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at April 04, 2023 19:53 / Updated at April 07, 2023 13:12